Chenrui Li

1.5k total citations
45 papers, 1.1k citations indexed

About

Chenrui Li is a scholar working on Molecular Biology, Cell Biology and Epidemiology. According to data from OpenAlex, Chenrui Li has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Cell Biology and 10 papers in Epidemiology. Recurrent topics in Chenrui Li's work include Endoplasmic Reticulum Stress and Disease (10 papers), Autophagy in Disease and Therapy (10 papers) and Mitochondrial Function and Pathology (8 papers). Chenrui Li is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (10 papers), Autophagy in Disease and Therapy (10 papers) and Mitochondrial Function and Pathology (8 papers). Chenrui Li collaborates with scholars based in China, Hong Kong and Australia. Chenrui Li's co-authors include Zhong Zuo, Ge Lin, Lin Sun, Ming Yang, Yachun Han, Hao Zhao, Shilu Luo, Jinfei Yang, Ying Xiao and Na Jiang and has published in prestigious journals such as PLoS ONE, Diabetes and Journal of Agricultural and Food Chemistry.

In The Last Decade

Chenrui Li

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chenrui Li China	18	566	228	219	189	146	45	1.1k
Lei Du China	28	761 1.3×	91 0.4×	335 1.5×	136 0.7×	216 1.5×	44	1.7k
Flori R. Sari Japan	19	569 1.0×	107 0.5×	139 0.6×	183 1.0×	112 0.8×	32	1.4k
Haruhisa Otani Japan	18	460 0.8×	120 0.5×	106 0.5×	130 0.7×	302 2.1×	46	1.5k
Mourad Ferdaoussi Canada	22	714 1.3×	138 0.6×	138 0.6×	134 0.7×	36 0.2×	43	1.7k
Jia Qi China	20	518 0.9×	103 0.5×	117 0.5×	44 0.2×	99 0.7×	55	1.1k
Gehan H. Heeba Egypt	25	458 0.8×	165 0.7×	166 0.8×	46 0.2×	44 0.3×	50	1.5k
Xiao Miao China	22	800 1.4×	76 0.3×	125 0.6×	101 0.5×	44 0.3×	29	1.6k
Eman Said Egypt	23	562 1.0×	188 0.8×	171 0.8×	31 0.2×	114 0.8×	71	1.4k
Runbin Sun China	22	667 1.2×	238 1.0×	219 1.0×	69 0.4×	34 0.2×	65	1.3k
Yunfeng Shen China	17	520 0.9×	184 0.8×	312 1.4×	39 0.2×	74 0.5×	46	1.3k

Countries citing papers authored by Chenrui Li

Since Specialization

Citations

This map shows the geographic impact of Chenrui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenrui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenrui Li more than expected).

Fields of papers citing papers by Chenrui Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenrui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenrui Li. The network helps show where Chenrui Li may publish in the future.

Co-authorship network of co-authors of Chenrui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chenrui Li. A scholar is included among the top collaborators of Chenrui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenrui Li. Chenrui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Guoliang, Jiwei Li, Ming Lü, et al.. (2025). Synthesis of Multivariate Indolo[3,2- b ]carbazole-Based Zr-MOFs via In Situ Synthetic Modification for Propane Recovery from Simulated Natural Gas. Inorganic Chemistry. 64(48). 23593–23601.

Li, Chenrui, Qing Zhao, Ming Yang, et al.. (2025). Mito-tempo ameliorates tubular injury of diabetic nephropathy via inhibiting mt-dsRNA release and PKR/eIF2α pathway activation. Free Radical Biology and Medicine. 237. 147–159. 1 indexed citations

Yang, Ming, Chongbin Liu, Na Jiang, et al.. (2025). Sesamol Ameliorates Lipid Deposition by Maintaining the Integrity of the Lipid Droplet–Mitochondria Connection in Diabetic Nephropathy. Journal of Agricultural and Food Chemistry. 73(3). 2124–2137. 2 indexed citations

Cao, Shiyu, Kang Gao, Yan‐Bing He, et al.. (2025). BMSC-derived exosomal CD73 mediated macrophage polarization promotes osteoblastic differentiation in diabetes. Experimental Cell Research. 450(2). 114653–114653.

Yang, Jinfei, Li Li, Chenrui Li, et al.. (2023). PACS-2 deficiency aggravates tubular injury in diabetic kidney disease by inhibiting ER-phagy. Cell Death and Disease. 14(10). 649–649. 9 indexed citations

Cai, Juan, Chenrui Li, Ming Yang, et al.. (2023). 4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling. Molecular Medicine. 29(1). 58–58. 43 indexed citations

Yang, Ming, Chongbin Liu, Na Jiang, et al.. (2023). Fibroblast growth factor 21 in metabolic syndrome. Frontiers in Endocrinology. 14. 1220426–1220426. 18 indexed citations

Yang, Ming, Chongbin Liu, Na Jiang, et al.. (2023). Mitochondrial homeostasis: a potential target for delaying renal aging. Frontiers in Pharmacology. 14. 1191517–1191517. 5 indexed citations

Liu, Yan, Chenrui Li, Li Li, et al.. (2023). DsbA-L interacting with catalase in peroxisome improves tubular oxidative damage in diabetic nephropathy. Redox Biology. 66. 102855–102855. 15 indexed citations

10.

Yang, Ming, Chongbin Liu, Na Jiang, et al.. (2023). Myostatin: a potential therapeutic target for metabolic syndrome. Frontiers in Endocrinology. 14. 1181913–1181913. 16 indexed citations

11.

Liu, Chongbin, Ming Yang, Li Li, et al.. (2022). A Glimpse of Inflammation and Anti-Inflammation Therapy in Diabetic Kidney Disease. Frontiers in Physiology. 13. 909569–909569. 11 indexed citations

12.

Yang, Jinfei, Chenrui Li, Yan Liu, et al.. (2022). Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease. Frontiers in Pharmacology. 13. 832299–832299. 7 indexed citations

13.

Li, Li, Chenrui Li, Chengyuan Tang, et al.. (2022). PACS-2 deficiency in tubular cells aggravates lipid-related kidney injury in diabetic kidney disease. Molecular Medicine. 28(1). 117–117. 20 indexed citations

14.

Duan, Junbo, Qing Wang, Bo Zhang, et al.. (2022). Accurate detection of atrial fibrillation events with R-R intervals from ECG signals. PLoS ONE. 17(8). e0271596–e0271596. 9 indexed citations

15.

Luo, Shilu, Ming Yang, Hao Zhao, et al.. (2022). Mitochondrial DNA-dependent inflammation in kidney diseases. International Immunopharmacology. 107. 108637–108637. 5 indexed citations

16.

Luo, Shilu, Ming Yang, Hao Zhao, et al.. (2021). Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease. Frontiers in Pharmacology. 12. 768100–768100. 24 indexed citations

17.

Yang, Ming, Chenrui Li, Shikun Yang, et al.. (2020). Mitophagy: A Novel Therapeutic Target for Treating DN. Current Medicinal Chemistry. 28(14). 2717–2728. 21 indexed citations

18.

Li, Chenrui, Li Li, Ming Yang, Lingfeng Zeng, & Lin Sun. (2020). PACS-2: A key regulator of mitochondria-associated membranes (MAMs). Pharmacological Research. 160. 105080–105080. 62 indexed citations

19.

Zou, Mingyang, et al.. (2020). Health information and health-seeking behaviour in Yemen: perspectives of health leaders, midwives and mothers in two rural areas of Yemen. BMC Pregnancy and Childbirth. 20(1). 404–404. 13 indexed citations

20.

Li, Zhang, Chenrui Li, Ge Lin, Péter Krajcsi, & Zhong Zuo. (2011). Hepatic Metabolism and Disposition of Baicalein via the Coupling of Conjugation Enzymes and Transporters—In Vitro and In Vivo Evidences. The AAPS Journal. 13(3). 378–89. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact